Hematuria in Sickle Cell Disease: Prevalence and Management
Hematuria is a common complication in patients with sickle cell disease, occurring frequently due to renal papillary necrosis and vaso-occlusive events in the renal medulla. The presence of blood in the urine can range from microscopic to severe gross hematuria requiring medical intervention.
Prevalence and Pathophysiology
Hematuria is a well-established complication in patients with sickle cell hemoglobinopathies, including both homozygous sickle cell disease (HbSS) and heterozygous sickle cell trait (HbAS) 1, 2.
The pathophysiology involves sickling of red blood cells in the renal medulla, where the unique countercurrent mechanism creates conditions prone to sickling, leading to vaso-occlusion and papillary necrosis 2, 3.
Hematuria can occur in both sickle cell disease and sickle cell trait, with the latter often having hematuria as the only clinical manifestation of sickling 3.
Clinical Presentation
Hematuria in sickle cell disease can present as:
Hematuria is typically unilateral and may be the only consequence of sickling in patients with sickle cell trait 3.
In severe cases, massive gross hematuria can occur, requiring urgent intervention 6.
Diagnostic Approach
Medical diagnosis of sickle cell-induced hematuria should be based on:
Imaging studies may be necessary to confirm the diagnosis and rule out other causes:
Management
Most episodes of hematuria in sickle cell disease are self-limiting and resolve with conservative management 1.
Conservative management includes:
For persistent or severe hematuria, several treatment options have been reported:
- Multiple doses of 1-desamino-8-D-arginine vasopressin (DDAVP) infusion have shown dramatic response in some cases of protracted gross hematuria 5
- Oral urea therapy has been reported to inhibit gelation of deoxygenated sickle hemoglobin and resolve hematuria within days 3
- Endourological approaches using balloon ureteral catheters to tamponade bleeding papillae have been successful in cases of massive hematuria 6
Surgical interventions such as partial or total nephrectomy are rarely needed and should be considered only after failure of medical management 5, 1.
Prevention and Follow-up
Patients with sickle cell disease should be monitored regularly for renal complications, including hematuria 4.
Preventive measures include:
Patients should be educated about the possibility of hematuria and instructed to seek medical attention if it occurs, especially if gross hematuria is present 4.
Special Considerations
In patients undergoing surgery, the risk of hematuria and other sickle cell-related complications may increase due to factors such as dehydration, hypoxia, and acidosis 4.
Careful perioperative management is essential to minimize these risks, including:
Patients with sickle cell disease often have impaired urinary concentrating ability and are at risk of dehydration, which can worsen hematuria 4.